As dementia cases grow, biomarkers and new therapies key to unlocking treatment

The BioWorld Insider Podcast
30/07/2021 34 min Temporada 1 Episodio 4
As dementia cases grow, biomarkers and new therapies key to unlocking treatment

Listen "As dementia cases grow, biomarkers and new therapies key to unlocking treatment"

Descargar episodio Ver en sitio original

Episode Synopsis

Howard Fillit, founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation, shares his insights on the impact of financial investments driving these therapies.

More episodes of the podcast The BioWorld Insider Podcast

Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – AUDIO 29/08/2025
Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – VIDEO 27/08/2025
The importance of balancing AI and people in drug development 27/05/2025
Two CEOs discuss bracing for tariffs, NIH grant cuts and gifting China biopharma leadership position 23/04/2025
As biopharma investments stumble, med tech surges 30/03/2025
Mega money well spent? Mammoth mergers fall short of the dream 24/02/2025
Healing the health divide for women 22/11/2024
Modifi gets creative on the rocky road to a multibillion-dollar buyout 13/11/2024
A quantum leap into the future of drug development 17/10/2024
Gene and cell therapies will propel innovation, says Astellas CCO 07/10/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA